Skip to content
Meta-analysis Open access

Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients

Nov 2026 · Lung · Vol 204 · 0 citations · 43 references
Medicine

Abstract

Randomized trials comparing the outcomes with catheter-directed medical thrombolysis (CDT) versus mechanical thrombectomy (MT) for patients with intermediate/high risk pulmonary embolism (PE) are limited. This meta-analysis aimed to assess the clinical outcomes after CDT versus MT for patients with intermediate/high risk PE. Eligible studies compared CDT and MT for patients with intermediate/high risk PE underwent catheter-based therapies were retrieved from a comprehensive literature search for PubMed, Web of Science, Scopus, and Cochrane CENTRAL through June 2026. Outcomes included all-cause mortality, major bleeding, and the length of intensive care unit (ICU) stay. Summary estimates were analyzed using a random effects model. A total of 18 studies (24,090 intermediate/high risk patients) were eligible for the analysis. CDT was associated with longer length of intensive care unit (ICU) stay (mean difference: 1.01 days, 95% confidence interval [CI] 0.87–1.15) compared with MT. While there was no statistical difference between the two groups regarding the risk of all-cause mortality (risk ratio [RR] 0.88, 95% CI 0.76–1.01, p = 0.068) and major bleeding (RR 1.07, 95% CI 0.74–1.55, p = 0.705). Similarly, the incidence of other clinical outcomes; all-cause readmission, PE-related readmission, blood transfusion rates, length of hospital stay, cardiac arrest, and stroke, were similar between the two groups. Among patients with intermediate/high risk PE treated with catheter-based therapies, there was no difference regarding the clinical outcomes between CDT and MT, but CDT was associated with a longer ICU stay. Larger, well designed randomized trials are needed to confirm these findings.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.